Atlas Trials

Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection

Clinical trial NCT01756924 · TERMINATED

Trial details

NCT number
NCT01756924
Sponsor
Arrevus Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Prosthetic Joint Infections of HipProsthetic Joint Infections of KneeInfected Spacers
Start date
2012-12-01
Primary completion
2014-07-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.